Ditchcarbon
  • Contact
  1. Organizations
  2. Miltenyi Biotec
Public Profile
Medical Device Manufacturing
DE
updated 11 days ago

Miltenyi Biotec

Company website

Miltenyi Biotec, a leading global biotechnology company headquartered in Germany (DE), has been at the forefront of innovative cell and gene therapy solutions since its founding in 1989. With a strong presence in Europe, North America, and Asia, the company focuses on developing advanced technologies for biomedical research and clinical applications. Specialising in cell separation, cell culture, and gene editing, Miltenyi Biotec offers unique products such as the MACS® Technology and the CliniMACS® Prodigy system, which streamline workflows and enhance research outcomes. Renowned for its commitment to quality and innovation, the company has achieved significant milestones, including the development of cutting-edge tools that support personalised medicine. Miltenyi Biotec's dedication to advancing scientific knowledge has solidified its position as a trusted partner in the life sciences industry, making it a key player in the ongoing evolution of therapeutic solutions.

DitchCarbon Score

How does Miltenyi Biotec's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

30

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Miltenyi Biotec's score of 30 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.

55%

Let us know if this data was useful to you

Miltenyi Biotec's reported carbon emissions

Miltenyi Biotec, headquartered in Germany, has made significant commitments towards achieving net-zero carbon emissions. As of 2023, the company has committed to long-term net-zero targets across all scopes of emissions, with a target year set for 2050. This commitment is part of their strategy to align with the Science Based Targets initiative (SBTi), which underscores their dedication to climate action. While specific emissions data for the most recent year is not available, Miltenyi Biotec's proactive stance in setting these targets reflects a growing trend within the pharmaceuticals, biotechnology, and life sciences sector to address climate change. The company is focused on reducing its carbon footprint and has established a framework to monitor and report on its progress towards these ambitious goals. Miltenyi Biotec's commitment to net-zero emissions is indicative of its recognition of the importance of sustainability in the industry. By pledging to achieve net-zero by 2050, the company aims to contribute positively to global efforts in combating climate change, although specific reduction percentages and interim targets have not been disclosed at this time.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Miltenyi Biotec's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Miltenyi Biotec is in DE, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Miltenyi Biotec is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Qiagen

DE
•
Other services (93)
Updated about 18 hours ago

Intrexon Bioinformatics Germany GmbH

DE
•
Computer and related services (72)
Updated 10 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

PharMingen

US
•
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Menarini Silicon Biosystems, S.p.A.

IT
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 15 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy